Based in Lyon, France, the International Agency for Research on Cancer is a widely respected body that produces assessments of carcinogens for use by regulators and researchers. But reputable scientists are now disassociating themselves from IARC and its research methods, a cancer epidemiologist at the Albert Einstein College of Medicine writes in Forbes. Read the full article on ASCH Dispatch.